Research ArticleArticle
A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
Vidya Perera
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Annette S. Gross
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Alan Forrest
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Cornelia B. Landersdorfer
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Hongmei Xu
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Sihem Ait-Oudhia
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
Andrew J. McLachlan
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (V.P., A.F., S.A.-O.); Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia (V.P., A.S.G., A.J.M.); Centre for Research and Education on Ageing, Concord Hospital, Concord, New South Wales, Australia (V.P., A.J.M.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline R&D, Sydney, New South Wales, Australia (A.S.G.); School of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia (C.B.L.); and Clinical Pharmacology and Pharmacometrics, AstraZeneca Pharmaceuticals, Wilmington, Delaware (H.X.)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Pharmacometrics of Caffeine and Paraxanthine
Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
Drug Metabolism and Disposition November 1, 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
Research ArticleArticle
Pharmacometrics of Caffeine and Paraxanthine
Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
Drug Metabolism and Disposition November 1, 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement